Former pharmaceutical executive Martin Shkreli, who is awaiting sentencing on three convicted counts in a securities fraud case, is on the hook for almost $10.5 million in losses to his investors, a federal judge has found.

Shkreli was convicted in August of two counts of securities fraud and a related conspiracy charge following a five-week trial, and was acquitted of five other charges.